Weight-loss drugs: Can Ozempic and other drugs change the landscape of India's wellness industry?
Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...
Impacts18d
What is Mounjaro and How does it Work?
Mounjaro is a famous medication used by adults above 18 years. Mounjaro weight loss medicine is super efficient in reducing sugar levels in type 2 diabetes patients and effectively loses a significant ...
Becker's Hospital Review19d
FDA: No more need for compounded versions of Mounjaro, Zepbound
The FDA has declared the end of the two-year shortages of Eli Lilly's Mounjaro and Zepbound — used to treat diabetes and weight loss, respectively — and has reaffirmed its decision to halt the ...
The Indianapolis Star19d
FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
On Thursday, the Food and Drug Administration said Eli Lilly's tirzepatide, sold as Zepbound for weight loss and Mounjaro to treat diabetes, is no longer in short supply. The FDA allows ...
PharmiWeb21d
Best Mounjaro Alternative Over the Counter: Cheaper, Safer Alternatives to Tirzepatide OTC
If you are considering a natural over the counter Mounjaro alternative for 2025 - we have the top 3 options for you. However, Mounjaro isn't the right fit for everyone. Since it's a prescription ...
The Business Journals22d
Eli Lilly's $3B expansion in Pleasant Prairie to begin this month, village says
See Correction/Clarification at the end of this article. Eli Lilly is the maker of high-in-demand injectable pharmaceuticals like Mounjaro, used for the treatment of diabetes and weight loss.
ENDPOINTS NEWS25d
EMA's com­mit­tee says ex­pand­ed la­bel for Lil­ly's Moun­jaro in­to sleep ap­nea not nec­es­sary
The Eu­ro­pean Med­i­cines Agency’s hu­man med­i­cines com­mit­tee (CHMP) hand­ed down 17 rec­om­men­da­tions for drug ap­provals on Fri­day but said a la­bel ex­pan­sion of ...
Bloomberg L.P.25d
Eli Lilly’s Mounjaro Won’t Have Separate Sleep Apnea Label in EU
Eli Lilly & Co.’s weight-loss and diabetes drug Mounjaro won’t be reclassified as a sleep apnea treatment in Europe, with regulators saying Friday that use of the drug is already covered in ...
Seeking Alpha26d
Lilly's Mounjaro does not need separate indication for sleep apnea, EMA panel determines
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), has determined that Eli Lilly's (NYSE:LLY) weight-loss drug Mounjaro (tirzepatide) does not need a separate ...
New York Post26d
Influencer who purchased ‘King Kong’ weight loss drug online warns of dangers: ‘Wish I’d never done it’
Georgie, from Great Yarmouth, Norfolk, England said his concerns followed his own experience of buying Mounjaro over the internet. Georgie Aldous, 26, is calling on online pharmacies to employ ...
Reuters26d
Lilly's Mounjaro more popular than Wegovy in UK's private obesity drug market
LONDON, Dec 13 (Reuters) - Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online pharmacies say, in a sign the U.S. drugmaker ...
Reuters26d
EU drugs regulator backs Mounjaro's sleep apnea use without fresh approval for Lilly
Dec 13 (Reuters) - The European Medicines Agency has allowed Eli Lilly (LLY.N), opens new tab to update the product label of its weight-loss drug Mounjaro to show it has benefit in treating a ...